Li Zhenshun, Zhou Wei, Yang Wanli, Miao Yan, Zhang Yujie, Duan Lili, Niu Liaoran, Chen Junfeng, Fan Aqiang, Xie Qibin, Wei Siyu, Bai Han, Wang Chenyang, Chen Xi, Han Yu, Hong Liu
Department of Digestive Surgery, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital of Digestive Diseases, Air Force Medical University.
Department of Histology and Embryology, School of Basic Medicine, Xi'an Medical University.
Int J Surg. 2024 Dec 1;110(12):8045-8056. doi: 10.1097/JS9.0000000000001826.
The emergence of robotic surgical systems compensated for the technological shortcomings of laparoscopic approaches. However, whether robotic gastrectomy (RG) has better perioperative outcomes and survival than laparoscopic gastrectomy (LG) for gastric cancer (GC) is still unclear but increasingly drawing attention.
In this systematic review and meta-analysis, we searched PubMed, EMBASE, Web of Science, and Cochrane Library as of 20 January 2024, and referenced a list of eligible articles for all published studies comparing RG and LG for patients with GC. Data on study characteristics, individual characteristics, and outcome parameters were extracted. The quality of studies was assessed using the Revised Cochrane risk-of-bias 2 tool and the risk of bias in nonrandomized studies of interventions tool. The main outcome measures were overall survival (OS) and disease-free survival (DFS).
The authors identified 3641 articles, of which 72 studies (30 081 patients) were included in the meta-analysis. Compared with LG, RG was associated with higher OS [hazard ratio (HR)=0.89, 95% CI=0.83-0.96], lower rate of overall postoperative complications [odds ratio (OR)=0.77, 95% CI=0.71-0.84], longer operating time [mean difference (MD)=35.53, 95% CI=29.23-41.83], less estimated blood loss (MD=-37.45, 95% CI=-46.24 to -28.67), a higher number of retrieved lymph nodes (MD=1.88, 95% CI=0.77-3.00), faster postoperative recovery, and lower rate of conversion (OR=0.44, 95% CI=0.36-0.55). Mortality and DFS were not significantly different between the two groups. The subgroup of meta-analysis results also showed the advantages of robotic surgery over laparoscopic surgery in intracorporeal reconstruction, total gastrectomy, Ⅰ/Ⅱ stage, and BMI≥25, especially for patients with stage Ⅰ/Ⅱ, there are better OS and DFS.
Our findings point to robotic surgery having great benefits compared with laparoscopic surgery in GC. Our study may help inform decision-making in applying robotic surgical systems to clinical treatment.
机器人手术系统的出现弥补了腹腔镜手术方法的技术缺陷。然而,对于胃癌(GC)患者,机器人胃切除术(RG)在围手术期结局和生存率方面是否优于腹腔镜胃切除术(LG)仍不明确,但越来越受到关注。
在本系统评价和荟萃分析中,我们检索了截至2024年1月20日的PubMed、EMBASE、Web of Science和Cochrane图书馆,并参考了所有已发表的比较RG和LG治疗GC患者的符合条件文章列表。提取了关于研究特征、个体特征和结局参数的数据。使用修订后的Cochrane偏倚风险2工具和干预性非随机研究中的偏倚风险工具评估研究质量。主要结局指标为总生存期(OS)和无病生存期(DFS)。
作者共识别出3641篇文章,其中72项研究(30081例患者)纳入荟萃分析。与LG相比,RG与更高的OS相关[风险比(HR)=0.89,95%置信区间(CI)=0.83 - 0.96],术后总体并发症发生率更低[优势比(OR)=0.77,95%CI=0.71 - 0.84],手术时间更长[平均差(MD)=35.53,95%CI=29.23 - 41.83],估计失血量更少(MD=-37.45,95%CI=-46.24至-28.67),获取的淋巴结数量更多(MD=1.88,95%CI=0.77 - 3.00),术后恢复更快,以及更低的中转率(OR=0.44,95%CI=0.36 - 0.55)。两组间死亡率和DFS无显著差异。荟萃分析结果的亚组分析还显示,机器人手术在体内重建、全胃切除术、Ⅰ/Ⅱ期以及体重指数(BMI)≥25的患者中优于腹腔镜手术,尤其是对于Ⅰ/Ⅱ期患者,有更好的OS和DFS。
我们的研究结果表明,在GC治疗中,机器人手术与腹腔镜手术相比具有很大优势。我们的研究可能有助于为将机器人手术系统应用于临床治疗提供决策依据。